156 related articles for article (PubMed ID: 25063898)
1. [Carcinosarcoma of the breast a rare entity with fatal prognosis. One case report].
Villalón-López JS; Souto-del Bosque R; Alonso-Briones MV; Trujillo-de Anda AP
Cir Cir; 2013; 81(4):328-32. PubMed ID: 25063898
[TBL] [Abstract][Full Text] [Related]
2. Metaplastic carcinoma of the breast: analysis of eight Asian patients with special emphasis on two unusual cases presenting with inflammatory-type breast cancer.
Kuo SH; Chen CL; Huang CS; Cheng AL
Anticancer Res; 2000; 20(3B):2219-22. PubMed ID: 10928181
[TBL] [Abstract][Full Text] [Related]
3. A case of breast carcinoma with cartilaginous and osseous metaplasia.
Kijima Y; Umekita Y; Yoshinaka H; Owaki T; Sakamoto A; Yoshida H; Aikou T
Breast Cancer; 2006; 13(2):214-9. PubMed ID: 16755121
[TBL] [Abstract][Full Text] [Related]
4. Metaplastic breast carcinoma: case series and review of the literature.
Esbah O; Turkoz FP; Turker I; Durnali A; Ekinci AS; Bal O; Sonmez OU; Budakoglu B; Arslan UY; Oksuzoglu B
Asian Pac J Cancer Prev; 2012; 13(9):4645-9. PubMed ID: 23167395
[TBL] [Abstract][Full Text] [Related]
5. [Two cases of HER2-positive advanced or metastatic breast cancer, responding to lapatinib and capecitabine].
Nakamura Y; Aono T; Nomura M; Iwase K; Tanaka Y
Gan To Kagaku Ryoho; 2010 Nov; 37(11):2165-8. PubMed ID: 21084819
[TBL] [Abstract][Full Text] [Related]
6. Carcinosarcoma of the breast: report of two cases.
Gogas J; Kouskos E; Markopoulos C; Mantas D; Antonopoulou Z; Kontzoglou K; Stamoulis J; Kyriakou V
Eur J Gynaecol Oncol; 2003; 24(1):93-5. PubMed ID: 12691330
[TBL] [Abstract][Full Text] [Related]
7. Predictive factors of pathologic complete response and clinical tumor progression after preoperative chemotherapy in patients with stage II and III breast cancer.
Jeong JH; Jung SY; Park IH; Lee KS; Kang HS; Kim SW; Kwon Y; Kim EA; Ko KL; Nam BH; Lee S; Ro J
Invest New Drugs; 2012 Feb; 30(1):408-16. PubMed ID: 20922557
[TBL] [Abstract][Full Text] [Related]
8. [Clinical features and prognosis of 25 cases of breast carcinosarcoma].
Yang YF; Liu J; Fang ZY; Gu L
Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):620-3. PubMed ID: 23158999
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant capecitabine, docetaxel, cyclophosphamide, and epirubicin for early breast cancer: final analysis of the randomized FinXX trial.
Joensuu H; Kellokumpu-Lehtinen PL; Huovinen R; Jukkola-Vuorinen A; Tanner M; Kokko R; Ahlgren J; Auvinen P; Paija O; Helle L; Villman K; Nyandoto P; Nilsson G; Pajunen M; Asola R; Poikonen P; Leinonen M; Kataja V; Bono P; Lindman H
J Clin Oncol; 2012 Jan; 30(1):11-8. PubMed ID: 22105826
[TBL] [Abstract][Full Text] [Related]
10. [A case of recurrent breast cancer in which gemcitabine-docetaxel therapy was successful for a long period].
Kakimoto M; Kawashima H; Koshiishi H; Miyamoto H; Okamura T
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2086-7. PubMed ID: 23267985
[TBL] [Abstract][Full Text] [Related]
11. Metaplastic breast cancer with a unique presentation and complete response to chemotherapy: a case report.
Nahhat F; Doyya M; Zabad K; Ksiri H
BMC Womens Health; 2024 May; 24(1):285. PubMed ID: 38734591
[TBL] [Abstract][Full Text] [Related]
12. [A case of breast cancer liver metastases responding to lapatinib and capecitabine therapy].
Sato T; Nakagawa T; Kuwayama T; Oda G; Sugimoto H; Ishiba T; Sugihara K
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2180-2. PubMed ID: 22202322
[TBL] [Abstract][Full Text] [Related]
13. Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer.
Curigliano G; Criscitiello C
J Clin Oncol; 2017 Aug; 35(23):2600-2603. PubMed ID: 28661760
[TBL] [Abstract][Full Text] [Related]
14. Breast carcinoma with choriocarcinomatous features: a case report and review of the literature.
Zhu Y; Liu M; Li J; Jing F; Linghu R; Guo X; Jiao S; Yang J
World J Surg Oncol; 2014 Jul; 12():239. PubMed ID: 25073898
[TBL] [Abstract][Full Text] [Related]
15. [A case of effective trastuzumab plus gemcitabine therapy for human epidermal growth factor receptor 2-positive breast cancer].
Yabe N; Murai S; Shimizu H; Kitasato K; Yoshikawa T; Oto I; Nakadai J; Jinno H; Kitagawa Y
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2396-8. PubMed ID: 24394124
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of docetaxel combined capecitabine on metastatic breast cancer].
Wang XX; Zhou ZM; Yuan ZY; Zhang DS; Shi YX; Jiang WQ
Ai Zheng; 2007 Apr; 26(4):407-10. PubMed ID: 17430662
[TBL] [Abstract][Full Text] [Related]
17. Capecitabine in addition to anthracycline- and taxane-based neoadjuvant treatment in patients with primary breast cancer: phase III GeparQuattro study.
von Minckwitz G; Rezai M; Loibl S; Fasching PA; Huober J; Tesch H; Bauerfeind I; Hilfrich J; Eidtmann H; Gerber B; Hanusch C; Kühn T; du Bois A; Blohmer JU; Thomssen C; Dan Costa S; Jackisch C; Kaufmann M; Mehta K; Untch M
J Clin Oncol; 2010 Apr; 28(12):2015-23. PubMed ID: 20308671
[TBL] [Abstract][Full Text] [Related]
18. [Combination of docetaxel and capecitabine for the treatment of anthracycline-resistant advanced breast carcinoma].
Zhang JD; Shao ZY
Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):787-9. PubMed ID: 19173816
[TBL] [Abstract][Full Text] [Related]
19. Metaplastic carcinoma of the breast with mesenchymal differentiation (carcinosarcoma). A unique presentation of an aggressive malignancy and literature review.
Salemis NS
Breast Dis; 2018; 37(3):169-175. PubMed ID: 29504519
[TBL] [Abstract][Full Text] [Related]
20. [A case of local advanced breast cancer with multiple lung metastases successfully treated with multimodal therapy].
Sengoku N; Kuranami M; Handa K; Hayashi K; Enomoto T; Watanabe M
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1927-9. PubMed ID: 15553762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
